Immortal Dragons, a purpose-driven longevity fund headquartered in Singapore, in the present day introduced its distinctive method to investing in radical life extension applied sciences. With $40 million in belongings below administration (AUM), Immortal Dragons is poised to redefine how capital fuels scientific breakthroughs in longevity and healthspan.
At its core, Immortal Dragons is pushed by a profound philosophy: to view growing old and demise not as inevitability, however as technical challenges that may be overcome by way of scientific innovation. This conviction underpins each funding choice, prioritizing impacts over monetary returns.
Moonshot Ventures
Immortal Dragons targets various areas inside the longevity sector. The fund has already invested in over 15 startups which can be on the forefront of those paradigm shifts, exploring applied sciences throughout a number of strategic pillars:
- Alternative & Regeneration: Together with pioneering analysis in xenotransplantation, cryopreservation, substitute or regeneration of organic elements.
- Gene Remedy: Gene therapies geared toward addressing the basis causes of growing old and age-related illnesses.
- 3D Bioprinting: 3D bioprinting of tissues and organs for therapeutic and regenerative functions.
- Longevity Infrastructure: Foundational ecosystem for longevity science, accelerated medical trials, and regulatory sandboxes.
Boyang Wang, the founding father of Immortal Dragons, articulated the fund’s method: “Whether or not it’s cutting-edge science or creating higher environments for analysis, we have to see the chance for actual affect.” [2] This dedication to various areas guides the fund in the direction of supporting what Boyang calls “moonshot initiatives push the boundaries of science, whereas infrastructure work – like particular financial zones – creates situations for broader success.” [2]
Objective-Pushed Capital
Working with the flexibleness of a single-LP construction, Immortal Dragons directs its personal capital in the direction of initiatives it’s most obsessed with, enabling swift and decisive motion. This mannequin permits the fund to assist underfunded however transformative analysis that conventional enterprise capital would possibly overlook.
“We are saying we’re a purpose-driven fund, and the important thing implication is that Immortal Dragons values affect over financial returns,” Boyang defined in his current interview. “I’m investing within the area of longevity as a result of I wish to see progress and breakthroughs within the sector.” [1]
This dedication extends to non-public conviction. Boyang Wang is notably among the many first 300 world recipients of Minicircle’s follistatin gene remedy, underscoring the fund’s willingness to embrace and take a look at frontier science. “The gene remedy is a private try, however this does replicate our threat profile and assist for the trigger,” Boyang defined, “We’ve robust motivation to assist the primary wave of longevity corporations to make revenue, in order to propel the funding flywheel.”
International Longevity Advocacy
Past typical investments, Immortal Dragons is devoted to fostering a world longevity advocacy. The fund actively engages in instructional outreach, and community-building initiatives, akin to translating scientific talks, translating and publishing longevity-themed books, internet hosting main chinese language longevity podcast channel, sponsorships and grants to longevity initiatives like Vitalist Bay, ARDD 2025. This method acknowledges that progress requires not solely monetary funding but in addition public consciousness and a sturdy infrastructure.
The fund’s advocacy method has been praised by main teachers within the area.
Professor Peter Lidsky of the Metropolis College of Hong Kong’s Biomedical Science division commented, “I used to be excited to fulfill Immortal Dragons workforce members on the Vitalist Bay, Berkeley earlier this yr. These are younger, courageous and energetic individuals dedicated to resolving the primary problem humanity faces: growing old. Their basis helped me lots in translating certainly one of my lectures to Chinese language, and I hope our collaboration will prosper sooner or later.”
With deep roots in each east and west, the fund is dedicated to bridge markets, capital, analysis and establishment by way of varied evangelism efforts.
Aubrey de Gray, president of the LEV Basis commented, “It has been a terrific pleasure to get to know the Immortal Dragons workforce. I’ve been annoyed for a few years that there was too little longevist exercise in China, and I’m delighted that that’s now altering, with the work of a gaggle that’s bringing my and others’ work to the Chinese language public. I’m additionally very completely happy that Immortal Dragons are investing in promising longevity startups.”
Immortal Dragons stands as a testomony to the ability of purpose-driven funding. By differentiating from the established order and providing a brand new perspective to human healthspan, the fund is on a mission to push boundaries and keep it up the torch or human life extension.
About Immortal Dragons:
Immortal Dragons (https://www.id.life/) is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, excessive affect applied sciences by supporting 15+ portfolio corporations. Past typical investments, the fund additionally places effort into longevity advocacy, together with: guide translation and publishing, translation of longevity chief’s talks, internet hosting main Chinese language longevity podcast, sponsorships and grants to longevity initiatives and conferences.
Contact:
Boyang Wang
Founding father of Immortal Dragons
Mailto: contact@id.life
References:
[1] Lifespan.io. (2025, June 9) Boyang Wang on Concentrating on Underfunded Longevity Initiatives. https://www.lifespan.io/news/boyang-wang-on-targeting-underfunded-longevity-projects
[2] Longevity.Know-how. (2025, June 30). Contained in the longevity fund that goals to ‘make demise non-obligatory’. https://longevity.technology/news/inside-the-longevity-fund-that-aims-to-make-death-optional/
